Menu
Pregnancy screening tests help doctors assess your baby’s health before birth and identify potential concerns at an early stage. One of the most commonly recommended first trimester screening tests is the double marker test. Read on to learn what the test checks, when it is performed, how to read the report, normal values, UAE pricing, and how it compares with NIPT and NT scan screening methods.
The double marker test is an early pregnancy screening test that helps estimate the risk of certain chromosomal abnormalities. It is commonly performed during the first trimester as part of routine prenatal screening.
Definition of Double Marker Test: The double marker test is a maternal blood screening test that measures Free Beta hCG and PAPP A levels to estimate the risk of chromosomal abnormalities such as Down syndrome and Edwards syndrome in the developing baby.
Why it is done in early pregnancy: Performing the test during the first trimester allows doctors to identify higher risk pregnancies early and recommend additional screening or diagnostic tests when required for better prenatal care planning.
Importance in prenatal screening: The test serves as an important component of first trimester screening because it combines blood marker analysis with ultrasound findings to provide a more reliable assessment of chromosomal abnormality risk.
The test helps estimate the likelihood of specific genetic and chromosomal conditions during pregnancy. It does not diagnose abnormalities but identifies pregnancies that may require additional evaluation.
The timing of the test plays a major role in screening accuracy. Hormone levels vary throughout pregnancy, making the recommended testing window important.
Ideal week, 9 to 13 weeks of pregnancy: Most doctors recommend performing the double marker test between the ninth and thirteenth week of pregnancy. Testing during this period allows hormone levels to be compared accurately with established pregnancy specific reference values.
Why early screening is important: Early identification of increased chromosomal risk provides more time for counseling, follow up testing, and informed pregnancy management decisions if additional investigations become necessary.
Relationship with first trimester screening: The double marker test is commonly combined with an NT scan and maternal age assessment as part of the standard first trimester screening protocol.
The procedure is simple, safe, and does not involve any invasive instruments entering the womb. Most women complete the test within a few minutes.
A healthcare professional collects a small blood sample from a vein in the mother’s arm. The sample is then sent to a laboratory for analysis of specific pregnancy related markers. The procedure is quick, safe, and usually does not require fasting.
Free Beta hCG is a hormone produced during pregnancy by placental tissue. Its level changes according to gestational age. Abnormal levels may influence risk calculations for chromosomal abnormalities, though the hormone alone cannot diagnose any condition.
PAPP A, or Pregnancy Associated Plasma Protein A, is a protein produced by the placenta. Lower than expected levels may be associated with increased chromosomal abnormality risk, making it an important marker in first trimester screening.
The double marker test is considered non invasive because only a maternal blood sample is collected. There is no direct contact with the baby, no surgical procedure, and no risk associated with invasive prenatal testing techniques.
Normal values vary according to gestational age and laboratory standards. Doctors usually evaluate hormone measurements together with MoM values and NT scan findings rather than relying on a single result.
Free Beta hCG levels vary significantly throughout pregnancy. Instead of focusing on a single numerical value, laboratories compare the result with expected levels for the specific week of pregnancy and calculate a standardized MoM value.
PAPP A levels normally increase as pregnancy progresses. Values are interpreted according to gestational age and laboratory reference standards. Lower levels may influence risk calculations when combined with other screening markers.
MoM stands for Multiple of the Median and compares an individual’s hormone level with the expected average value for the same pregnancy stage. Values around 1.0 MoM are generally considered reassuring in many screening reports.
A normal result usually shows hormone values within expected pregnancy ranges and a low risk assessment after combining maternal age, blood marker results, and NT scan measurements.
Abnormally high or low hormone values can affect risk calculations for chromosomal abnormalities. However, these values alone cannot confirm a diagnosis and should always be interpreted by a qualified healthcare provider.
Combined risk calculation uses blood marker levels, maternal age, gestational age, and NT scan findings. This approach provides a more accurate risk estimate than evaluating individual markers separately.
A double marker test report contains hormone measurements, MoM values, and risk calculations. Doctors review all report sections together before interpreting the overall screening outcome.
How to read the report: The report generally includes patient details, gestational age, hormone measurements, MoM values, calculated risk ratios, and an interpretation summary prepared using specialized screening software.
Risk ratio interpretation, low risk and high risk: A low risk result indicates a lower probability of chromosomal abnormalities, while a high risk result suggests an increased probability and may require additional testing.
Role of ultrasound NT scan with blood test: NT scan measurements significantly improve screening accuracy when combined with blood marker analysis and maternal age information.
What screen positive means: A screen positive result indicates an increased estimated risk, not a confirmed diagnosis. Many pregnancies with screen positive results ultimately have healthy babies.
A negative result generally provides reassurance but should always be interpreted within the broader context of pregnancy care and routine prenatal follow up.
A double marker test negative result means the calculated risk of chromosomal abnormalities is lower than the laboratory’s high risk threshold. While reassuring, it does not completely eliminate the possibility of genetic conditions because screening tests estimate risk rather than provide definitive diagnoses.
Both tests help assess chromosomal abnormality risk during pregnancy, but they differ in accuracy, technology, and cost. The choice depends on medical history, risk level, and doctor recommendations.
NIPT, or Non Invasive Prenatal Testing, analyzes fragments of fetal DNA circulating in the mother’s blood. It offers significantly higher screening accuracy for common chromosomal abnormalities and is often recommended for higher risk pregnancies.
|
Feature |
Double Marker Test |
NIPT |
|
Sample Required |
Maternal blood |
Maternal blood |
|
Accuracy |
Good screening accuracy |
Higher screening accuracy |
|
Cost |
Lower |
Higher |
|
Purpose |
Risk estimation |
Advanced risk estimation |
|
Availability |
Widely available |
Increasingly available |
|
Follow Up Need |
Sometimes required |
Less frequently required |
Although both tests are performed during the first trimester, they evaluate different indicators. Together they provide a more complete assessment of pregnancy risk.
The double marker test evaluates pregnancy related hormones in the mother’s blood, while the NT scan uses ultrasound imaging to measure fluid accumulation behind the baby’s neck.
Combining blood marker analysis with ultrasound findings improves screening performance and provides more reliable risk calculations than using either test independently.
The double marker test and NT scan together form the foundation of first trimester chromosomal abnormality screening in many healthcare facilities worldwide.
The cost of the test varies depending on the laboratory, hospital, city, and package inclusions. Some facilities offer bundled screening packages that include ultrasound examinations.
The average price of a double marker test in the UAE generally ranges from AED 250 to AED 800. Prices may increase when NT scan services, specialist consultations, or comprehensive prenatal screening packages are included within the same appointment.
Pricing differences can occur between emirates due to healthcare provider policies, equipment, and package offerings.
Finding a testing center is usually straightforward because most maternity hospitals and diagnostic laboratories provide prenatal screening services.
A normal report typically contains several sections that help doctors assess overall screening risk and determine whether additional testing is necessary.
Many patients search for double marker test normal report images before receiving their results. While report layouts vary between laboratories, most follow a similar format.
A typical report includes patient details, gestational age, blood marker values, MoM calculations, NT scan findings if available, and a final risk interpretation. Report formats differ between laboratories, so only a healthcare professional should provide medical interpretation.
Hormone levels continue to change throughout pregnancy. Therefore, values considered normal at thirteen weeks may differ from those seen earlier in the first trimester.
At thirteen weeks, Free Beta hCG and PAPP A levels are interpreted using gestational age specific reference ranges. Laboratories adjust calculations using MoM values to ensure results remain comparable despite natural hormonal changes during pregnancy.
Different laboratories may report hormone measurements using different units. Therefore, reference ranges can vary between facilities.
Free Beta hCG values may be reported using laboratory specific measurement units. Doctors usually focus on gestational age adjusted interpretation rather than comparing raw numerical values alone.
PAPP A measurements may also appear in ng/ml or other laboratory defined units. Reference intervals differ depending on testing methodology and pregnancy week.
MoM values standardize hormone measurements by comparing them with expected averages for a specific pregnancy stage. This helps improve consistency across different laboratories and testing systems.
Medical coding helps healthcare providers process billing, insurance claims, and documentation more efficiently during laboratory testing and prenatal screening services.
A CPT code is a standardized medical billing code used by healthcare providers and insurance companies. Hospitals use these codes to identify specific laboratory procedures, facilitate claim processing, and maintain accurate healthcare documentation records.
A high risk result can cause anxiety, but it is important to remember that screening tests estimate probability rather than confirm abnormalities.
A positive or high risk result indicates that the calculated probability of certain chromosomal abnormalities is above the laboratory’s predefined threshold. Additional testing is often recommended to clarify whether a genetic condition is actually present.
A negative result is generally considered a favorable screening outcome and is seen in the majority of pregnancies undergoing routine prenatal screening.
The result indicates that the estimated risk of screened chromosomal abnormalities is low based on available screening data. Routine pregnancy care, scheduled scans, and regular prenatal consultations should continue according to medical advice.
The test may be recommended routinely or because of specific risk factors identified during pregnancy assessment.
While useful for screening, the test has certain limitations that should be understood before interpreting results.
The double marker test plays an important role in first trimester prenatal screening by helping identify pregnancies with increased chromosomal abnormality risk. When combined with an NT scan, it provides more reliable risk assessment and helps doctors determine whether additional testing is necessary. With wide availability across UAE diagnostic centers and hospitals, the test remains a valuable option for early pregnancy screening and informed prenatal care.
Looking for reliable pregnancy screening and diagnostic services in Dubai? MVR provides trusted and advanced diagnostic care supported by modern technology, high quality laboratory standards, and experienced healthcare professionals. From prenatal screening tests such as the double marker test to a wide range of diagnostic services, MVR focuses on delivering accurate and timely results while ensuring patient comfort throughout the process. Affordable screening and diagnostic packages are available, helping expectant mothers access quality healthcare and essential testing with confidence and convenience.
What is a double marker test in pregnancy?
A double marker test is a first trimester blood screening test that evaluates Free Beta hCG and PAPP A levels to estimate chromosomal abnormality risk.
What is the normal range for double marker test?
Normal ranges vary according to pregnancy week and laboratory standards. Most doctors rely on MoM values and overall risk calculations for interpretation.
Is double marker test necessary?
Many doctors recommend it as part of first trimester screening because it helps identify pregnancies that may require additional evaluation.
What is better, double marker or NIPT?
NIPT generally provides higher screening accuracy, while the double marker test remains a more affordable and widely available option.
What does double marker test negative mean?
A negative result indicates a lower estimated risk of chromosomal abnormalities but does not completely eliminate risk.
How much does double marker test cost in UAE?
The test generally costs between AED 250 and AED 800 depending on the healthcare provider and package inclusions.
In which week is double marker test done?
The test is usually performed between the ninth and thirteenth week of pregnancy.
MVR Diagnostic Clinic provides advanced diagnostic, radiology known for precision, convenience, and affordable care—your trusted healthcare partner.